Novonesis stock gains support from a EUR 75 million buyback

Published on 09/15/2026 at 18:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novonesis stock starts a EUR 75 million buyback on September 14, 2026. The program follows 8 percent organic sales growth in H1 2026 and a raised 2026 outlook.

Industrieanlage mit Fermentationstanks eines daenischen Biotech-Unternehmens — Fotorealistische Ansicht einer Biotech-Anlage von Novonesis (Novozymes), ISIN DK0060336014, mit modernen Fermentationstanks in Bagsvaerd, Illustration mit AI erstellt.

Novonesis stock (ISIN DK0060336014) is supported by the start of a EUR 75 million first tranche of its buyback program, which the company announced on September 14, 2026. Novonesis said the tranche is part of a EUR 1 billion multi-year plan and is set to run until no later than December 17, 2026.Globenewswire

H1 numbers still matter

In its August 19, 2026 update, Novonesis said first-half organic sales growth was 8 percent, with Q2 at 9 percent, while adjusted EBITDA margin reached 37.7 percent in H1 and 37.6 percent in Q2.Global Agriculture The company also lifted its 2026 organic sales growth outlook to 7 percent to 8 percent from 5 percent to 7 percent and said the adjusted EBITDA margin is expected at the higher end of 37 percent to 38 percent.Global Agriculture

Buyback size and pace

Novonesis said the first tranche corresponds to around 1.3 million B shares based on the closing share price on September 11, 2026, and that daily purchases will not exceed 25 percent of average volume on Nasdaq Copenhagen over the preceding 20 business days.Globenewswire For investors, the key point is that the company is pairing a capital return program with a margin profile that it now pegs at 37 percent to 38 percent for 2026.Global Agriculture

Price and market view

Novonesis B shares last had a visible price stamp as of September 15, 2026 on Morningstar, while MarketScreener showed Nasdaq Copenhagen trading around DKK 280.40 on September 14, 2026, after a 1.43 percent move and a 6.21 percent year-to-date decline. The same MarketScreener snapshot listed an average target price of DKK 310.17, implying a spread of 10.62 percent to the last close.MarketScreener